Skip to content
  • Home
  • About us
  • Products
    ELISA kit
    • HIV infection
    • Viral Hepatitis
    • Syphilis
    • Herpes Infections
    • TORCH Infections
    • Vaccine-Preventable Diseases
    • Сovid-19COVID-19 is an infectious disease caused by a new SARS-CoV-2 coronavirus which had not previously been detected in humans. The viral infection leads to the development of a respiratory flu-like disease with symptoms such as cough and fever. In more severe cases pneumonia can develop. The average incubation period of the COVID-19 is 6.5 days, but it can range from 3 to 21 days. SARS-CoV-2 is an RNA-virus with a specific envelope with spikes in the form of a “corona”. The main structural proteins of the virus include envelope protein (E), membrane protein (M), spike (S) glycoprotein, and nucleocapsid (N) protein. S protein on the surface of the SARS-CoV-2 virion mediates the receptor recognition and cell membrane fusion with ACE2 molecules, which are mainly expressed on type II pneumocytes, colon and kidney epithelial cells. It contains three fragments, namely the ectodomain, the transmembrane domain and the short intracellular segment. The ectodomain consists of a receptor-binding subunit S1 containing the RBD domain and a fusion subunit (S2). During viral infection, S1 C-terminal domain binds to the extracellular peptidase (PD) domain of ACE2 to ensure that the virus attaches to the surface of the target cell. The S1 N-terminal domain binds to…
    • Borreliosis
    • Parasites
    • Urogenital Infections
    • Gastroenteric Diseases
    • Tumor Markers
    • Metabolism
    • Allergy
    • Biotinylated Allergens
    • Thyroid function
    Download catalog ELISA kits
    IMMUNOGLOBULINS LEVEL
    Raw materials
    DOWNLOAD CATALOG RAW MATERIALS
  • News
  • Contact
  • EN
  • UA
  • RU
  • Home
  • About us
  • Products
    • ELISA kits
      • HIV infection
      • Parasites
      • Syphilis
      • Borreliosis
      • Viral Hepatitis
      • TORCH Infections
      • Herpes Infections
      • Vaccine-Preventable Diseases
      • Сovid-19COVID-19 is an infectious disease caused by a new SARS-CoV-2 coronavirus which had not previously been detected in humans. The viral infection leads to the development of a respiratory flu-like disease with symptoms such as cough and fever. In more severe cases pneumonia can develop. The average incubation period of the COVID-19 is 6.5 days, but it can range from 3 to 21 days. SARS-CoV-2 is an RNA-virus with a specific envelope with spikes in the form of a “corona”. The main structural proteins of the virus include envelope protein (E), membrane protein (M), spike (S) glycoprotein, and nucleocapsid (N) protein. S protein on the surface of the SARS-CoV-2 virion mediates the receptor recognition and cell membrane fusion with ACE2 molecules, which are mainly expressed on type II pneumocytes, colon and kidney epithelial cells. It contains three fragments, namely the ectodomain, the transmembrane domain and the short intracellular segment. The ectodomain consists of a receptor-binding subunit S1 containing the RBD domain and a fusion subunit (S2). During viral infection, S1 C-terminal domain binds to the extracellular peptidase (PD) domain of ACE2 to ensure that the virus attaches to the surface of the target cell. The S1 N-terminal domain binds to…
      • Urogenital Infections
      • Gastroenteric Diseases
      • Tumor Markers
      • Metabolism
      • Allergy
      • Biotinylated Allergens
      • Thyroid function
    • IMMUNOGLOBULINS LEVEL
    • RAW MATERIALS
    • DOWNLOAD CATALOG ELISA
    • DOWNLOAD CATALOG RAW MATERIALS
  • News
  • Contact
  • EN
    • EN
    • UA
    • RU
  • DOWNLOAD CATALOG ELISA
  • Home
  • About us
  • Products
    • ELISA kits
      • HIV infection
      • Parasites
      • Syphilis
      • Borreliosis
      • Viral Hepatitis
      • TORCH Infections
      • Herpes Infections
      • Vaccine-Preventable Diseases
      • Сovid-19COVID-19 is an infectious disease caused by a new SARS-CoV-2 coronavirus which had not previously been detected in humans. The viral infection leads to the development of a respiratory flu-like disease with symptoms such as cough and fever. In more severe cases pneumonia can develop. The average incubation period of the COVID-19 is 6.5 days, but it can range from 3 to 21 days. SARS-CoV-2 is an RNA-virus with a specific envelope with spikes in the form of a “corona”. The main structural proteins of the virus include envelope protein (E), membrane protein (M), spike (S) glycoprotein, and nucleocapsid (N) protein. S protein on the surface of the SARS-CoV-2 virion mediates the receptor recognition and cell membrane fusion with ACE2 molecules, which are mainly expressed on type II pneumocytes, colon and kidney epithelial cells. It contains three fragments, namely the ectodomain, the transmembrane domain and the short intracellular segment. The ectodomain consists of a receptor-binding subunit S1 containing the RBD domain and a fusion subunit (S2). During viral infection, S1 C-terminal domain binds to the extracellular peptidase (PD) domain of ACE2 to ensure that the virus attaches to the surface of the target cell. The S1 N-terminal domain binds to…
      • Urogenital Infections
      • Gastroenteric Diseases
      • Tumor Markers
      • Metabolism
      • Allergy
      • Biotinylated Allergens
      • Thyroid function
    • IMMUNOGLOBULINS LEVEL
    • RAW MATERIALS
    • DOWNLOAD CATALOG ELISA
    • DOWNLOAD CATALOG RAW MATERIALS
  • News
  • Contact
  • EN
    • EN
    • UA
    • RU
  • DOWNLOAD CATALOG ELISA

Vitrotest® Anti-Strongyloides

Home page » Products » Vitrotest® Anti-Strongyloides
  • Description

  • Features

  • Strongyloidiasis

  • Description

The test kit Vitrotest® Anti-Strongyloides is an enzyme linked immunosorbent assay (ELISA) for the detection of IgG class antibodies to Strongyloides stercoralis in human serum or plasma.

Determination of IgG antibodies to Strongyloides stercoralis in the test kit Vitrotest® Anti-Strongyloides is based on a solid phase, indirect ELISA in a two-step incubation procedure.

  • ТК146 – 96 tests

  • Features

  • Solid phase: breakable microplate ELISA is coated Strongyloides stercoralis antigens.
  • Conjugate: a monoclonal antibodies to human IgG conjugated to horseradish peroxidase.
  • Chromogen: ready to use TMB solution.
  • Volume of sample for analysis: 10 μl.
  • Assay time: 40 min.

  • Strongyloidiasis

Strongyloidiasis is a chronic parasitic infection of humans caused by Strongyloides stercoralis. This helminth is predominantly found in tropical and subtropical regions but can also be present in temperate climates. It is estimated that approximately 300 to 600 million people worldwide are infected.

Primary infection occurs when S. stercoralis larvae penetrate human skin through direct contact with contaminated soil. The larvae migrate via the bloodstream and lymphatic system to the respiratory tract, where they are then coughed up and swallowed, reaching the intestines. In the intestines, the parasites develop into adult worms, lay eggs, and produce larvae that can be excreted in the feces. A unique feature of S. stercoralis is its ability to cause autoinfection, as larvae may re-enter the intestines or perianal skin without leaving the host, leading to persistent infection.

In immunocompetent individuals, uncomplicated strongyloidiasis may be asymptomatic or present with mild cutaneous and gastrointestinal symptoms. Often, the only sign of infection is unexplained peripheral eosinophilia. However, in cases of heavy infestation or in immunosuppressed patients, the disease can cause severe manifestations such as abdominal pain, watery diarrhea, constipation, weight loss, vomiting, or small bowel obstruction. Hyperinfection syndrome is the most severe manifestation of the disease, with high mortality rates.

Parasitological methods (microscopy, culture) are traditionally used for diagnosis. The sensitivity and specifi city of these tests, however, are not high. The standard stool examination has a sensitivity of only 21% (5). Serological methods, especially enzyme-linked immunosorbent assay (ELISA), are highly sensitive and convenient for detecting antibodies to S. stercoralis larvae. ELISA is widely used for screening, diagnosing strongyloidiasis, and monitoring treatment effi cacy, as antibody titers signifi cantly decline within the fi rst 6 months following successful eradication therapy.

ELISA kits, Parasites

tel./fax: +380972227672, +380442227672 | e-mail: info@vitrotest.ua, order@vitrotest.ua

© Vitrotest 2006 - 2026 | All Rights Reserved | Privacy policy | Terms of use

Page load link
Go to Top